Brought to you by 
Cambrex acquires Marathon for $26mm
12 Sep 2002
Executive Summary
Cambrex (life sciences products) has acquired the biopharmaceutical producer Marathon Pharmaceuticals from discovery-stage drug company CoPharma for $26mm in a cash for stock transaction. Marathon will operate as part of Cambrex's contract manufacturing division Cambrex Bio Science.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cambrex acquires Marathon for $26mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice